Browse by Audience
Skip to content
Papers of the Week
A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria: A real-world study in Belgium.
Abstract
Chronic spontaneous urticaria (CSU) is characterized by the repeated occurrence by persistent hives and/or angioedema for ≥6 weeks, without specific external stimuli. H -antihistamines have long been the standard of care of CSU, but many patients remain uncontrolled even at 4× the approved dose. Add-on therapy with omalizumab has proven effective in clinical trials, but little is known about omalizumab treatment in Belgium.